Alpha DNA Investment Management’s JPMorgan Chase JPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$547K Buy
1,888
+16
+0.9% +$4.08K 6.09% 5
2025
Q1
$459K Sell
1,872
-18,976
-91% -$4.84M 6.01% 6
2024
Q4
$5M Sell
20,848
-299
-1% -$69.6K 1.9% 6
2024
Q3
$4.46M Buy
21,147
+8,434
+66% +$1.78M 1.67% 6
2024
Q2
$2.57M Sell
12,713
-11,151
-47% -$2.18M 1% 10
2024
Q1
$4.78M Sell
23,864
-2,928
-11% -$528K 1.77% 4
2023
Q4
$4.56M Sell
26,792
-4,872
-15% -$738K 1.78% 4
2023
Q3
$4.59M Sell
31,664
-751
-2% -$113K 1.88% 3
2023
Q2
$4.71M Buy
32,415
+1,995
+7% +$274K 1.57% 3
2023
Q1
$3.96M Sell
30,420
-8,034
-21% -$1.1M 1.17% 7
2022
Q4
$5.16M Buy
38,454
+16,777
+77% +$2.13M 1.82% 3
2022
Q3
$2.27M Buy
+21,677
New +$2.49M 1.88% 5
2021
Q2
Sell
-762
Closed -$115K 371
2021
Q1
$115K Buy
762
+189
+33% +$27.2K 0.13% 117
2020
Q4
$72K Buy
+573
New +$64K 0.08% 144

Other funds holding JPM

Alpha DNA Investment Management's JPM Position: Q2 2025 in Review

Alpha DNA Investment Management increased its JPMorgan Chase (JPM) stake by 0.85% in Q2 2025, buying an estimated $4.08K and bringing the position to 1,888 shares worth $547K. The position accounts for 6.09% of the portfolio, ranked #5.

Alpha DNA Investment Management first reported a position in JPM in Q4 2020 and has held it in 14 quarters since. The position peaked at $5.16M in Q4 2022. 4,740 funds tracked by Wall St. Rank hold JPM as of Q2 2025.

  • Alpha DNA Investment Management held 1,888 shares of JPMorgan Chase worth $547K as of Q2 2025.
  • Alpha DNA Investment Management bought 16 JPMorgan Chase shares in Q2 2025, an estimated $4.08K.
  • JPMorgan Chase made up 6.09% of Alpha DNA Investment Management's portfolio in Q2 2025, its #5 holding.
  • Alpha DNA Investment Management first reported a position in JPMorgan Chase in Q4 2020 and has held it in 14 quarters since.
  • Alpha DNA Investment Management's JPMorgan Chase position peaked at $5.16M in Q4 2022.
  • 4,740 funds tracked by Wall St. Rank held JPMorgan Chase as of Q2 2025.

Based on Alpha DNA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.